ArticleThe Journal of infection2023

Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?

Robert Marcec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.